XING Shuang,HU Zhi-qing,LI Ming,HUANG Hai-xiao,OU Hong-ling,ZHAO Jian-zhi,XIONG Guo-lin,XIE Ling,ZHAO Zhen-hu,WANG Ning,WANG Jin-xiang,ZHANG Ri,MIAO Jing-cheng,ZHU Nan-kang,CONG Yu-wen,LUO Qing-liang,ZHANG Xue-guang.Experimental therapeutic effect of combined cytokines on beagle dogs exposed to 4.5 Gy γ-rays[J].Chinese Journal of Radiological Medicine and Protection,2010,30(3):243-246
Experimental therapeutic effect of combined cytokines on beagle dogs exposed to 4.5 Gy γ-rays
Received:December 24, 2009  
DOI:10.3760/cma.j.issn.0254-5098.2010.03.003
KeyWords:Cytokine  Acute radiation sickness  Recombinant human interleukin-11  Recombinant human G-CSF  Recombinant human interleukin-2  Beagles
FundProject:国防科工委"十一五"核科学基础研究重点项目(A3620060130)
Author NameAffiliationE-mail
XING Shuang Institute of Radiation Medicine, Academy of Military Medical Sciences, Beijing 100850, China  
HU Zhi-qing 苏州大学医学  
LI Ming Institute of Radiation Medicine, Academy of Military Medical Sciences, Beijing 100850, China  
HUANG Hai-xiao Institute of Radiation Medicine, Academy of Military Medical Sciences, Beijing 100850, China  
OU Hong-ling 第二炮兵总医院  
ZHAO Jian-zhi 苏州大学附属第一医院  
XIONG Guo-lin Institute of Radiation Medicine, Academy of Military Medical Sciences, Beijing 100850, China  
XIE Ling Institute of Radiation Medicine, Academy of Military Medical Sciences, Beijing 100850, China  
ZHAO Zhen-hu Institute of Radiation Medicine, Academy of Military Medical Sciences, Beijing 100850, China  
WANG Ning Institute of Radiation Medicine, Academy of Military Medical Sciences, Beijing 100850, China  
WANG Jin-xiang 苏州大学医学  
ZHANG Ri 苏州大学附属第一医院  
MIAO Jing-cheng 苏州大学医学  
ZHU Nan-kang 苏州大学医学  
CONG Yu-wen Institute of Radiation Medicine, Academy of Military Medical Sciences, Beijing 100850, China  
LUO Qing-liang 100850 北京, 军事医学科学院放射与辐射研究所  
ZHANG Xue-guang 苏州大学医学 xgzh@ yahoo. com. cn 
Hits: 4160
Download times: 2782
Abstract::
      Objective To evaluate the effects of combined administration of recombinant human interleukin-11 (rhIL-11), recombinant human G-CSF (rhG-CSF) and recombinant human interleukin-2 (rhIL-2) on acute radiation sickness (ARS) beagles. Methods Sixteen beagle were irradiated with 4.5 Gy 60Coγ-rays to establish ARS models, and were divided into irradiation control group, supportive care group and combined cytokines treatment group. After irradiation irradiation control group was given no treatment, the dogs in supportive care group received purely symptomatic treatment, while combined cytokines treatment group received rhIL-11 50μg/(kg ?d) and rhG-CSF 10μg/(kg ?d) subcutaneously(0-14 d) and rhIL-2 1?106 U/d (29-43 d) besides symptomatic treatment. Manifestation and characteristics of ARS beagles were observed, and the survival time were recorded. At last, post-mortem examination and histological examination were performed. Results All animals underwent nausea, diarrhea and fever. After irradiation, all animals in irradiation control group died in two weeks, and the mean survival time was 12.7 d, while only one died at 33 d in supportive care group. All dogs in combined cytokine group survived at 45 day after exposure, and their haematopoiesis and gastrointestinal tract were recovered. Conclusions Combination of rhIL-11 rhG-CSF rhIL-2 treatment could be significantly effective on ARS beagles irradiated by 4.5 Gy 60Coγ-rays, which could accelerate injured haemotopoiesis and intestinal tract recovery, increase the survival rate and improve the life quality of animals.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9067839  On-line:0

v
Scan QR Code
&et=3B5D9771435A916B9F5CF2A882D88DC29CAC6D1ED35888FBF7296B4562CB9F5C8E5B0B0F89B1C60297841BC82BD75F88131F7A7E5DBA075CA03BAF6C390F8DEC51C5EF18FBEC8A7AF9DC83CAFD352C2D45D72BADF0EABD66C9462CF83C241AA9&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=140ECF96957D60B2&aid=0496A7CFAC4121367EC22090CF7A3912&vid=&iid=38B194292C032A66&sid=B78CD622C1934236&eid=28F9D9CF04F424FF&fileno=20110303&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="140ECF96957D60B2"; var my_aid="0496A7CFAC4121367EC22090CF7A3912";